Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

ISH 2016

18 - 21 Apr 2016
Scottish Exhibition and Conference Centre (SECC), Glasgow, United Kingdom
Hodgkins - update on treatment strategies in children and adolescents
Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany
Hodgkins - update on treatment strategies in children and adolescents ( Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany )
6 May 2016
Use of novel agents in childhood ALL
Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016
Oncology for children: what can be done when resources are scarce?
Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi
Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )
6 May 2016
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016
Relapsed Hodgkin lymphoma in PET positive patients
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016
Comment on RESONATE2 and CLL115 trials
Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Comment on RESONATE2 and CLL115 trials ( Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )
29 Apr 2016
Clinical cases employing novel agents in Hodgkin lymphoma
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA
Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )
29 Apr 2016
Microenvironment of chronic lymphocytic leukaemia
Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridg...
Microenvironment of chronic lymphocytic leukaemia ( Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016
Current trials in chronic lymphocytic leukaemia
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambrid...
Current trials in chronic lymphocytic leukaemia ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016
Chronic lymphocytic leukaemia: Transition to a new era
Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL
Prof Jan Burger, MD Anderson Cancer Center, Texas, USA
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ( Prof Jan Burger, MD Anderson Cancer Center, Texas, USA )
29 Apr 2016
The role of the microenvironment and novel therapies in CLL
Prof Jan Burger - MD Anderson Cancer Center, Texas, USA
The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )
29 Apr 2016
AML17 Trial results: maximum dosage of daunorubicin in AML
Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016
AML during pregancy
Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
AML during pregancy ( Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK )
27 Apr 2016
Germ line predisposition to leukaemia
Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA
Germ line predisposition to leukaemia ( Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA )
27 Apr 2016
The future of haematopathology
Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016
Frontline therapy in young patients with myeloma
Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016
Genomics of childhood ALL
Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel
Genomics of childhood ALL ( Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel )
27 Apr 2016
BSH 2016: Expert discussion on idelalisib
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016
BSH 2016: Expert discussion on front line care in CLL
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016